smallRW.gif (2706 bytes) Internet-Based Technologies Impact on Clinical Trials To Be Addressed by Merck, Pharmacia, and Aventis at CRO-Pharma Partnerships Conference in Washington, DC, on October 10-11

WASHINGTON, Aug. 30 /PRNewswire/ -- "Sponsor - CRO Clinical Partnerships Meet the Future," a high-level executive meeting organized to analyze the new market forces driving industry profitability and cost containment, will address as a conference highlight discussion of the impact of Internet-based efforts in clinical research areas, announces Strategic Research Institute. Speakers from pharma giants Merck, Pharmacia Corporation and Aventis will be featured on this topic. The conference will take place in Alexandria, VA on October 10-11 of this year.

The pharma speakers will discuss on their panels the huge impact of web-based technologies in clinical trials, such as:

  • The impact of new technologies on service providers and the transformation into a virtual document process
  • Pros and cons of the integration of the Internet in clinical trials
  • Faster and more efficient patient recruitment
  • Remotely managing the clinical research process
  • On-line site or personnel training
  • Privacy/confidentiality concerns
  • Easier data management
  • Innovative technologies

The conference is distinguished by the high-level executive participation from the pharmaceutical, CRO, regulatory, legal, site, internet, financial, academic, and other members of the clinical research community who will convene for two days to discuss the future of the industry. The agenda is detailed below.

To register or request additional information, contact Glenn Pascual at gpascual@srinstitute.com or 212-967-0095, x245.

For sponsorship and exhibition opportunities, contact Mark Alexay at malexay@hotmail.com or 212-967-0095, x251.

AGENDA

Panel Discussion: A Look at Market Forces Shaping the Clinical Trials Industry

This session will focus on five primary forces that are impacting the clinical trials industry today. The issues include:

1. Mergers and Pressures on CROs

2. Regulatory Requirements (impact on IRBs)

3. Emerging study conduct providers (hospitals, independent research centers, large networks)

4. Productivity performance pressures

5. Technology trends

Moderator:

Joan A. Kroll, Product & Marketing Manager, CENTERWATCH

Panelists:

Michael A. Martorelli, CFA, Managing Director, Research, PENNSYLVANIA MERCHANT GROUP

Gary Chadwick, PharmD, MPH, Executive Director, UNIVERSITY OF ROCHESTER

Mark Di Ianni, Executive Vice President, SCIREX, INC.

Samuel T. Barnett, Partner, PRICE WATERHOUSE COOPERS

Jim Patricelli, Director, DEUTSCHE BANC ALEX. BROWN

Panel Discussion: Industry Consolidation & Deal-Making: Impact of Mergers & Acquisitions on Service Providers -- Solutions & Concerns

Michael A. Martorelli, CFA, Managing Director, Research, PENNSYLVANIA MERCHANT GROUP

Bruce Kreter, Vice President, Clinical Research, KENDLE INTERNATIONAL

Mark Harvill, Director, Business Development, STATPROBE

Panel Discussion: What Is the Future Role for Niche Providers: Can Too Many Cooks Spoil the Broth?

Moderator:

Kathy Cox, Ph.D., President, PHARMASEEK, INC.

Panelists:

Christopher T. Speh, MA, MBA, President, RESOURCE SOLUTIONS, INC.

Kathleen Harper, FUJISAWA

Ann Devine, OMNICARE

Panel Discussion: Global Outsourcing Strategies: The Evolution of Strategic Alliances

Maria Malae Dotson, Vice President, Global Clinical Operations, QUINTILES, INC. (invited)

Jack Vandeventer, Director, Global Sourcing, ELI LILLY & COMPANY

Gene Richardson, Director, Global Strategic Alliances, RW JOHNSON, PRI

Panel Discussion: Current Trends in the Evolving Relationships Between Service Providers

Moderator:

Susan Callery-D'Amico, Ph.D., Senior Director, Global Clinical Operations, RW JOHNSON PRI

Panelists:

Bob Aromondo, Director, COVANCE, INC.

Paul Ottaviano, MS, MBA, Executive VP, World Wide Operations and COO, CLINTRIALS RESEARCH INC.

Leslie Cate, Vice President Clinical Operations, nTOUCH RESEARCH CORPORATION

Frank Willis, J.D., Executive Vice President, LYNN HEALTH SCIENCE INSTITUTE

Panel Discussion: The Evolving Role of Scientific, Regulatory, and Legal Consulting in Catalyzing Partnerships Among Developers, Investors, and CROs

Moderator:

Gilbert Alexander Fleming, M.D., Senior VP, Global Regulatory Affairs, WORLDWIDE CLINICAL TRIALS, INC./INGENIX INTERNATIONAL, (Former Member of the FDA)

Panelists:

Frank Sasinowski, Esq., Counsel, HYMAN, PHELPS, & MCNAMARA

David Lepay, M.D., Recently appointed Chief Clinical Advisor, Office of the Commissioner, FDA

W. Leigh Thompson Jr. MD, PhD, Former Chief Scientific Officer, ELI LILLY & COMPANY

Alexander Walker, M.D., recently retired chairman, Dept of Epidemiology, HARVARD SCHOOL OF PUBLIC HEALTH (and VP, EPIDEMIOLOGY RESEARCH INSTITUTE)

Alan Moses, M.D., Chief Medical Officer, Joslin Clinic, HARVARD MEDICAL SCHOOL

Ronald Waife, President, WAIFE & ASSOCIATES

Panel Discussion: Risk Sharing in the Partnership or Is the Partnership at Risk? Strategies for the Future in Sponsor/Service Provider Relationships (5 Year Forecast)

Moderator:

William Orr, Ph.D., President & CEO, LYNN HEALTH SCIENCE INSTITUTE

Panelists:

Carole Sampson- Landers, Ph.D., Executive Medical Director, BRISTOL-MYERS SQUIBB

Pat O'Connor, MRCP, Ph.D., Senior VP, Global Clinical Affairs, PPD DEVELOPMENT

Steve Rauscher, CEO, AMERICASDOCTOR.COM

Frank Willis, J.D., Executive Vice President, LYNN HEALTH SCIENCE INSTITUTE

Teresa Stem, Ph.D., President, TQM RESEARCH

Panel Discussion: Evolving Issues in Patient Recruitment Today: Trends and Solutions for Tomorrow

Moderator:

Diana Anderson, Ph.D., President and CEO, RHEUMATOLOGY RESEARCH INTERNATIONAL, INC.

Panelists:

Lisa Felkins, RN, BSN, Senior Project Manager, Product Experience, GENENTECH, INC. (invited)

Susan Krivacic, Ph.D., Senior VP of Marketing & Business Development, CLINICOR, INC.

Noah Berkowitz, M.D., Ph.D., Vice President Information Services, IMPATH

John Ogle, Former Chief Scientific Officer, QUINTILES AMERICA (invited)

Panel Discussion: A Look into the Future of Web-Based Systems: The Impact of New Technologies on Service Providers and The Transformation into a Virtual Document Process

Moderator:

Ronald Waife, Ph.D., President, WAIFE & ASSOCIATES, INC.

Panelists:

Gregory Holmes, PharmD, Executive Vice President, Clinical Operations, SFBC INTERNATIONAL, INC.

Daniel Fakouhi, M.D., Senior Director, Clinical Trial Affairs, PHARMACIA CORPORATION

Adrian Otte, Ph.D., Chief Operating Officer, INNOVATIVE CLINICAL SOLUTIONS, LTD

Art Shedden, MD, MBA, Director, Clinical Research, MERCK & COMPANY

SOURCE: Strategic Research Institute

ST: District of Columbia, Virginia


This press release may not be redistributed without prior written approval by PR Newswire.


Posted August 30, 2000.

Go to:

Press Release Archives

RiskWorld homepage

Tec-Com Inc.